Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Zacks Small-Cap Research Sets $1.16 Price Target On Kiora Pharmaceuticals

Zacks Small-Cap Research Sets $1.16 Price Target On Kiora Pharmaceuticals

KPRX_SCIR_081522 (q4cdn.com)

byBenzinga Newsdesk

August 15, 2022

1 minute read

KPRX_SCIR_081522 (q4cdn.com)

Elon Musk Sheds Tesla Shares Valued At $6.8B — In First Such Sale Since April

By Shivdeep Dhaliwal

August 9, 10:26 PM

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk sold $6.85 billion worth of the electric-vehicle maker's shares, according to filings made with the U.S. Securities and Exchange Commission on Tuesday.

TSLA

UBS Maintains Buy on Charles Schwab, Raises Price Target to $82

By Benzinga Newsdesk

July 29, 10:27 AM

UBS analyst Brennan Hawken maintains Charles Schwab (NYSE:SCHW) with a Buy and raises the price target from $75 to $82.

SCHW

Watching Joby Aviation; Kerrisdale Capital Issues Short Report On Co Titled “Prepare For Turbulence”

By Benzinga Newsdesk

October 10, 8:59 AM

https://www.kerrisdalecap.com/wp-content/uploads/2023/10/Joby-Aviation-JOBY.pdf

JOBY

Levi Strauss’ Strong Business Model To Drive Growth In 2023, Says Analyst

By Lekha Gupta

April 6, 1:18 PM

Telsey Advisory Group analyst Dana Telsey reiterated an Outperform rating on Levi Strauss & Co (NYSE:LEVI) and a price target of $24 following…

LEVI

Zacks Small-Cap Research Sets $1.16 Price Target On Kiora Pharmaceuticals

Related Posts

Elon Musk Sheds Tesla Shares Valued At $6.8B — In First Such Sale Since April

UBS Maintains Buy on Charles Schwab, Raises Price Target to $82

Watching Joby Aviation; Kerrisdale Capital Issues Short Report On Co Titled “Prepare For Turbulence”

Levi Strauss’ Strong Business Model To Drive Growth In 2023, Says Analyst